Abstract
In the mid-1960s it was reported that removal of the neurointermediate lobe of the pituitary results in a disturbance of shuttle-box avoidance behavior of rats (De Wied 1965). Subsequent studies revealed that treatment with vasopressin normalizes the disturbed behavior of posterior lobectomized rats, and it was also shown that the disturbed behavior is unrelated to the disturbance in water metabolism (De Wied 1969). Later it appeared that pitressin or vasopressin given during either the acquisition or the extinction period of shuttle-box avoidance behavior induces a long-lasting resistance to extinction of the learned avoidance response in intact rats (De Wied and Bohus 1966; De Wied et al. 1974) Similar effects were obtained in a one-way active avoidance paradigm (De Wied 1971; Schulz et al. 1974; Koob et al. 1981, 1986). A single injection of vasopressin induced a long-term, dose-dependent inhibition of extinction of the conditioned avoidance response. This effect was still present after the administered peptide had disappeared from the body, which suggests that vasopressin triggers a long-term effect on the maintenance of a learned response (De Wied 1971; De Wied et al. 1974, 1976; Van Wimersma Greidanus et al. 1973; Stark et al. 1978). Similar or comparable effects have been reported by other researchers (Schulz et al. 1974; Koob et al. 1981; Le Moal et al. 1981), but still others have failed in this respect (see for review Saghal 1984). The critical time period for this behavior effect of vasopressin to occur lasted some hours. Vasopressin was fully active when administered in association with behavior that occurred 1 h prior to or after injection (King and De Wied 1974). Administration 3 h before or after the behavioral session markedly decreased the effectiveness of the treatment, while administration at a time interval of 6 h was ineffective (De Wied 1971, 1973; Bohus et al. 1972).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ader R, De Wied D (1972) Effects of lysine vasopressin on passive avoidance learning. Psychon Sci 29: 46–48
Ader R, Weijnen JAWM, Moleman P (1972) Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychon Sci 26: 125–128
Alliot J, Alexinsky T (1982) Effects of posttrial vasopressin injections on appetitively motivated learning in rats. Physiol Behav 28: 525–530
Asin KE (1980) Lysine vasopressin attenuation of dietyldithiocarbamate-induced amnesia. Pharmacol Biochem Behav 12: 343–346
Beckwith BE, Tinius TP (1985) Vasopressin and vasotocin facilitate reversal of a brightness discrimination. Peptides 6: 383–386
Beckwith BE, Tinius TP, Miller DH (1987) Arginine vasopressin facilitates reversal and impairs retention of a brightness discrimination in albino rats. Psychobiology 15: 329–335
Bluthé R-M, Dantzer R, Mormède P, Le Moal M (1985) Specificity of aversive stimulus properties of vasopressin. Psychopharmacology (Berlin) 87: 238–241
Bohus B (1977) Effects of desglycinamide-lysine vasopressin (DG-LVP) on sexually motivated Tmaze behavior of the male rat. Horm Behav 8: 52–61
Bohus B, Ader R, De Wied D (1972) Effects of vasopressin on active and passive avoidance behavior. Horm Behav 3: 191–197
Bohus B, Kovacs GL, De Wied D (1978a) Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Res 157: 414–417
Bohus B, Urban I, Van Wimersma Greidanus TB, De Wied D (1978b) Opposite effects of oxytocin and vasopressin on avoidance behavior and hippocampal theta rhythm in the rat. Neuropharmacology 17: 239–247
Bohus B, Conti L, Kovacs GL, Versteeg DHG (1982) Modulation of memory processes by neuropeptides: interaction with neurotransmitter systems. In: Marsan CA, Matthies H (eds) Neuronal plasticity and memory formation. Raven, New York, pp 75–87
Bookin HB, Pfeiffer WD (1977) Effect of lysine vasopressin on penthylenetetrazol-induced retrograde amnesia in rats. Pharmacol Biochem Behav 7: 51–54
Burbach JPH, Kovacs GL, De Wied D, Van Nispen JW, Greven HM (1983) A major metabolite of arginine-vasopressin in the brain is a highly potent neuropeptide. Science 221: 1310–1312
Buresova O, Skopkova J (1982) Vasopressin analogues and spatial working memory in the 24-arm radial maze. Peptides 3: 725–728
Cools AR, Broekkamp CLE, Gieles LCM, Megens A, Mortiaux HJGM (1977) Site of action of development of partial tolerance to morphine in cats Psychoneuroendocrinology 2: 17–33
Couk DI, Beckwith BE (1982) Effects of desmopressin acetate ( DDAVP) on the learning of a brightness discrimination. Peptides 5: 521–526
Dantzer R, Bluthé RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berlin) 91: 363–368
Davis JL, Pico RM (1984) Arginine vasotocin delays extinction of a conditioned avoidance behavior in neonatal chicks. Peptides 5: 1221–1223
Davis JL, Pico RM, Cherkin A (1982) Arginine vasopressin enhances memory retroactively in chicks. Behav Neural Biol 35: 242–250
Delanoy RL, Dunn AJ, Tintner R (1978) Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice. Horm Behav 11: 348–362
De Vry J, Donselaar I, Van Ree JM (1988) Effects of desglycinamide9, (ARG8)vasopressin and vasopressin antiserum on the acquisition of intravenous cocaine self-administration in the rat. Life Sci 42: 2709–2715
De Wied D (1965) The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats. Int J Neuropharmacol 4: 157–167
De Wied D (1969) Effects of peptide hormones on behavior. In: Ganong WF, Martini L (eds) Frontiers in neuroendocrinology. Oxford University Press, London, pp 97–104
De Wied D (1971) Long-term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature 232: 58–60
De Wied D (1973) The role of the posterior pituitary and its peptides on the maintenance of conditioned avoidance behaviour. In: Lissak K (ed) Hormones and brain function. Plenum, New York, pp 391–397
De Wied D (1976) Behavioral effects of i.v.c. administered vasopressin and vasopressin fragments. Life Sci 19: 685–690
De Wied D (1984) Neurohypophyseal hormone influences on learning and memory processes. In: Lynch G, McGaugh JL, Weinberger NM (eds) Neurobiology of learning and memory. Guildford Press, New York, pp 289–312
De Wied D, Bohus B (1966) Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and a-MSH. Nature 212: 1484–1486
De Wied D, Gispen WH (1976) Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus. Psychopharmacology (Berlin) 46: 27–29
De Wied D, Van Wimersma Greidanus TB (1976) Vasopressin and memory consolidation. Prog Brain Res 45: 181–194
De Wied D, Greven HM, Lande S, Witter A (1972) Dissociation of the behavioral and endocrine effects of lysine vasopressin by tryptic digestion. Br J Pharmacol 45: 118–122
De Wied D, Bohus B, Van Wimersma Greidanus TB (1974) The hypothalamic-neurohypophyseal system and preservation of conditioned avoidance behavior in rats. Prog Brain Res 41: 417–428
De Wied D, Gaffori O, Burbach JPH, Kovâcs GL, Van Ree JM (1987) Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J Pharmacol Exp Ther 241: 268–274
De Wied D, Joëls M, Burbach JPH, De Jong W, De Kloet ER, Gaffori OWJ, Urban IJA, Van Ree JM, Van Wimersma Greidanus TB, Veldhuis HD, Versteeg DHG, Wiegant VM (1988) Vasopressin effects on the central nervous system. In: Negro-Vilar A, Conn PM (eds) Peptide hormones: effects and mechanisms of action, vol I. CRC Press, Boca Raton, pp 97–140
Ettenberg A, Le Moal M, Koob GF, Bloom FE (1983) Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin. Pharmacol Biochem Behav 18:645–647
Ermisch A, Landgraf R, Möbius P (1986) Vasopressin and oxytocin in brain areas of rats with high or low behavioral performance. Brain Res 379: 24–29
Ettenberg A, Le Moal M, Koob GF, Bloom FE (1983) Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin. Pharmacol Biochem Behav 18: 645–647
Fekete M, Van Ree JM, De Wied D (1986) The ACTH-(4–9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats. Peptides 7: 563–568
Ferris CF, Albers HE, Wesolowski SM, Goldman BD, Luman SE (1984) Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters. Science 224: 521–523
Ferris CF, Singer EA, Meenan DM, Alber HE (1988) Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists. Eur J Pharmacol 154: 153–159
Finkelberg F, Kalant H, Le Blanc AE (1978) Effect of vasopressin-like peptides on consumption of ethanol by the rat. Pharmacol Biochem Behav 9: 453–458
Flexner JB, Flexner LB, Hoffman PL, Walter R (1977) Dose-response relationships in attenuation of puromycin-induced amnesia by neurohypophyseal peptides. Brain Res 134: 139–144
Fraenkel HM, Van Bee-Verbeek G, Fabriek AJ, Van Ree JM (1983) Desglycinamide9-arginine8-vasopressin and ambulant methadone-detoxification of heroin addicts. Alcohol Alcohol 18: 331–335
Gaffori IJW, De Wied D (1986) Time-related memory effects of vasopressin analogues in rats. Pharmacol Biochem Behav 25: 1125–1129
Garrud P (1975) Effects of lysine-8-vasopressin on punishment-induced suppression of a lever-holding response. Prog Brain Res 42: 173–186
Garrud P, Gray JA, De Wied D (1974) Pituitary-adrenal hormones and extinction of rewarded behavior in the rat. Physiol Behav 12: 109–119
Gold PE, Van Buskirk R (1976) Effects of posttrial hormone injections on memory processes. Horm Behav 7: 509–517
Hamburger R, Sela A, Belmaker RH (1985) Differences in learning and extinction in response to vasopressin in six inbred mouse strains. Psychopharmacology (Berlin) 87: 124–125
Hamburger-Bar R, Klein A, Belmaker RH (1985) The effect of chronic vs. acute injection of vasopressin on animal learning and memory. Peptides 6: 23–25
Hartmann G, Schwarzberg H, Hahn Z (1979) Behavioural and humoral effects of vasopressin after intracerebral administration. Acta Physiol Acad Sci Hung 53: 174
Hijman R, Jolles J, Verhoeven WMA, Van Ree JM, Elderson A, De Wied D (1990) Desglycinamide-(ARG8)-vasopressin affects cognitive performance in mild brain trauma patients (to be published)
Hoffman PL, Ritzmann RF, Walter R, Tabakoff B (1978) Arginine vasopressin maintains ethanol tolerance. Nature 276: 614–616
Höglung AU, Meyerson BJ (1982) Effects of lysine-vasopressin in an exploratory behaviour test situation. Physiol Behav 29: 189–193
Hostetter G, Jubb SL, Kozlowski GP (1977) Vasopressin affects the behavior of rats in a positively rewarded discrimination task. Life Sci 21: 1323–1328
Hostetter G, Jubb SL, Kozlowski GP (1980) An inability of subcutaneous vasopressin to affect passive avoidance behavior. Neuroendocrinology 30: 174–177
Jenkins JS, Mather HM, Coughlan AK, Jenkins DG (1981) Desmopressin and desglycinamide: vasopressin in post-traumatic amnesia. Lancet i:38–39
Jolies J (1983) Vasopressin-like peptides and the treatment of memory disorders in man. Prog Brain Res 60: 169–182
Jolies J (1985) Early diagnosis of dementia: possible contributions from neuropsychology. In: Gispen WH, Traber J (eds) Aging of the brain. Springer, Berlin Heidelberg New York, pp 84–100
Jolies J (1987) Vasopressin and human behavior. In: Gash CD, Boer GJ (eds) Vasopressin, principles and properties. Plenum, New York, pp 549–578
Judge ME, Quatermain D (1982) Alleviation of anisomycin-induced amnesia by pretest treatment with lysine-vasopressin. Pharmacol Biochem Behav 16: 463–466
King AR, De Wied D (1974) Localized behavioral effects of vasopressin on maintenance of an active avoidance response in rats. Comp Physiol Psychol 86: 1008–1018
King MG, Stinus L, Le Moal M, Geffard M (1982) Central administration of arginine vasotocin: effects on exploratory behavior in the rat. Psychopharmacology (Berlin) 76: 40–43
Koob GF, Le Moal M, Gaffori O, Manning M, Sawyer WH, Rivier J, Bloom FE (1981) Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats. Regul Pept 2: 153–163
Koob GF, Dantzer R, Bluthé R-M, LeBrun C, Bloom FE, Le Moal M (1986) Central injections of arginine vasopressin prolong extinction of active avoidance. Peptides 7: 213–218
Kovacs GL, Bohus B, Versteeg DHG, De Kloet ER, De Wied D (1979) Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local micro-injection into limbic-midbrain structure. Brain Res 175: 303–314
Kovacs GL, Vécsei L, Medve L, Telegdy G (1980) Effect on memory processes of anti-vasopressin serum micro-injected into the dorsal raphe nucleus: the role of catecholaminergic neurotransmission. Exp Brain Res 38: 357–361
Kovacs GL, Buijs RM, Bohus B, Van Wimersma Greidanus TB (1982) Micro-injection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats. Physiol Behav 28: 45–48
Krejci I, Kupkovâ B (1978) Effects of vasopressin analogues on passive avoidance behavior. Act Nery Super (Praha) 20: 11–12
Krejci I, Kupkovâ B, Metys J, Barth T, Jost K (1979) Vasopressin analogs: sedative properties and passive avoidance behavior in rats. Eur J Pharmacol 56: 347–353
Krivoy WA, Zimmerman E, Lande S (1974) Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine-vasopressin. Proc Natl Acad Sci USA 71: 1852–1856
Lâczi F, Valkusz Zs, Laszlo FA, Wagner A, Jardanhazy T, Szasz A, Szliârd J, Teledgy G (1982) Effects of lysine-vasopressin and 1-desamino-8-D-arginine-vasopressin on the memory in healthy individuals and diabetes insipidus patients. Psychoneuronendocrinology 7: 185–193
Lâczi F, Gaffori O, De Kloet ER, De Wied D (1983a) Differential responses in immunoreactive arginine-vasopressin content of microdissected regions during passive avoidance behavior. Brain Res 260: 342–346
Lâczi F, Gaffori O, De Kloet ER, De Wied D (1983b) Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. Brain Res 280: 309–315
Lâczi F, Van Ree JM, Vagner A, Walkusz Zs, Jardanhazy T, Kovacs GL, Telegdy G, Szilard J, Laszlo FA, De Wied D (1983c) Effects of desglycinamide-arginine-vasopressin ( DGAVP) on memory processes in diabetes insipidus patients and in non-diabetic subjects. Acta Endocrinol (Copenh) 102: 205–212
Lâczi F, Lâszl FA, Kovacs GL, Telegdy G, Szâsz A, Szilard J, Van Ree JM, De Wied D (1987) Differential effect of desglycinamide9-(Arg)8-vasopressin on cognitive functions of diabetes insispidus and alcoholic patients. Acta Endocrinol (Copenh) 115: 393–398
Lande S, Witter A, De Wied D (1971) Pituitary peptides. An octapeptide that stimulates conditioned avoidance acquisition in hypophysectomized rats. J Biol Chem 246: 2058–2062
Lande S, Flexner JB, Flexner B (1972) Effect of corticotropin and desglycinamide9-lysine vaso- pressin on suppression of memory by puromycin. Proc Natl Acad Sci USA 69: 558–560
LeBrun CJ, Rigter H, Martinez JL Jr, Koob GF, Le Moal M, Bloom FE (1984) Antagonism of effects of vasopressin ( AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP]. Life Sci 35: 1505–1512
Leccese AP, Isenkour JL (1983) Intraventricular administration of antivasopressin serum inhibits retention in mice. Peptides 4: 265–267
Lee RJ, Lomax P (1983) Thermoregulatory, behavioral and seizure modulatory effects of AVP in the Gerbil. Peptides 4: 801–805
Legros JJ (1975) The radioimmunoassay of human neurophysins: contribution to the understanding of the physiopathology of neuropophysial function. Ann NY Acad Sci 248: 282–303
Legros JJ, Lancranjan I (1984) Vasopressin in neuropsychiatrie disorders. In: Nadkmar SS, Donald AG (eds) Psychoneuroendocrine dysfunction. Plenum, New York, pp 255–278
Le Moal M, Koob GF, Koda LY, Bloom FE, Manning M, Sawyer WH, Rivier J (1981) Vasopressor receptor antagonist prevents behavioral effects of vasopressin. Nature 291: 491–493
Leshner AI, Mixon JF (1980) Neuropeptide effects of learning in social environments. Proceedings of the 27th Congress of the International Union of Physiological Science, Budapest, no 0397
Leshner AI, Roche KE (1977) Comparison of the effect on ACTH and lysine vasopressin on avoid-ance-of-attack in mice. Physiol Behav 18: 879–883
Leshner AI, Hofstein R, Samuel D, Van Wimersma Greidanus TB (1978) Intraventricular injection of antivasopressin serum blocks learned helpnessness in rats. Pharmacol Biochem Behav 9: 889–892
Lissak K, Bohus B (1972) Pituitary hormones and avoidance behavior of the rat. Int J Physiobiol 2: 103–115
Luerssen TG, Robertson GL (1980) Cerebrospinal fluid vasopressin and vasotocin in health. In: Wood JH (ed) Neurobiology of cerebrospinal fluid. Plenum, New York, pp 613–625
Lukowiak K, Thornhill JA, Cooper KE, Veale WL (1980) Vasopressin increases the central nervous system suppressive control over gill reflex behaviours and associated neural activity in Aplysia. Can J Physiol Pharmacol 58: 583–587
Martin JT, Van Wimersma Greidanus TB (1978) Imprinting behavior: influences of vasopressin and ACTH analogues. Psychoneuroendocrinology 3: 261–269
Meisenberg G (1981) Short-term behavioral effects of posterior pituitary peptides in mice. Peptides 2: 1–8
Meisenberg G, Simmons WH (1982) Behavioral effects of intracerebroventricularly administered neurohypophyseal hormone analogs in mice. Pharmacol Biochem Behav 16: 819–825
Messing RB, Sparber SB (1983) Des-Gly-vasopressin improves acquisition and slows extinction of autoshaped behavior. Eur J Pharmacol 89: 43–51
Messing RB, Sparber SB (1984) Does vasopressin really facilitate memory processes? Trends Pharmacol Sci April:149–152
Nebes RD, Raynolds CF III, Horn LC (1984) The effect of vasopressin on memory in the healthy elderly. Psychiatry Res 11: 49–59
Pfeiffer WD, Bookin HB (1978) Vasopressin antagonizes retrograde amnesia in rats following electroconvulsive shock. Pharmacol Biochem Behav 9: 261–263
Rigter H (1982) Vasopressin and memory. The influence of prior experience with the training situation. Behav Neural Biol 34: 337–351
Rigter H, Popping A (1976) Hormonal influences on the extinction of conditioned taste aversion. Psychopharmacology (Berlin) 46: 255–261
Rigter H, Van Riezen H, De Wied D (1974) The effect of ACTH- and vasopressin analogues on CO2-induced retrograde amnesia in rats. Physiol Behav 13: 381–388
Rigter H, Rijk H, Crabbe JC (1980) Tolerance to ethanol and severity of withdrawal in mice are enhanced by a vasopressin fragment. Eur J Pharmacol 64: 53–68
Rossor MN, Iversen LL, Mountjoy CQ, Roth M, Hawthorn J, Ang VY, Jenkins JS (1980) Arginine vasopressin and choline acetyl-transferase in brains of patients with Alzheimer type senile dementia. Lancet 2: 1367–1368
Sadile AG (1979) Neuropeptide hormones and behavioral habituation. Neurosci Lett [Suppl]3:S90
Sahgal A (1984) A critique of the vasopressin-memory hypothesis. Psychopharmacology (Berlin) 83: 215–228
Sahgal A, Wright C (1984) Choice, as opposed to latency, measures in avoidance suggest that vasopressin and oxytocin do not affect memory in rats. Neurosci Lett 48: 299–304
Sahgal A, Keith AB, Wright C, Edwardson JA (1982) Failure of vasopressin to enhance memory in a passive avoidance task in rats. Neurosci Lett 28: 87–92
Schulz H, Kovacs GL, Telegdy G (1974) Effect of physiological doses of vasopressin and oxytocin on avoidance and exploratory behaviour in rats. Acta Physiol Acad Sci Hung 45: 211–215
Gkopkova J, Lat J, Dvorskd I, Hrbas P, Radil T (1987) The effect of AVP and DGAVP on the exploratory activity of rats. Peptides 8: 785–790
Södersten P, Henning M, Melin P, Ludin S (1983) Vasopressin alters female sexual behaviour by acting on the brain independently of alterations in blood pressure. Nature 301: 608–610
Södersten P, Boer GJ, De Vries GJ, Buijs RM, Melin P (1986) Effects of vasopressin on female sexual behavior in male rats. Neurosci Lett 69: 188–191
Stark H, Bigi H, Sterba G (1978) Effects of posterior-pituitary-lobe peptides on the maintenance of a conditioned avoidance response in rats. In: Bargmann W, Oksche A, Polenov A, Schnarrer B (eds) Neurosecretion and neuroendocrine activity. Springer, Berlin Heidelberg New York, p 292
Sundquist J, Forsling ML, Olsson JE, Äkerlund M (1983) Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. J Neurol Neurosurg Psychiatry 46: 14–17
Swaab DF, Fliers E, Hoogendijk JE (1987) Vasopressin in relationship to human aging and dementia. In: Gash DM, Boer GJ (eds) Vasopressin, principles and properties. Plenum, New York, pp 611–625
Teal JJ, Evans HL (1982) Effects of DDAVP, a vasopressin analog, on delayed matching behavior in the pigeon. Pharmacol Biochem Behav 17: 1123–1127
Thor DH, Holloway WR (1982) Social memory of the male laboratory rat. J Comp Physiol Psychol 96: 1000–1006
Tinius TP, Beckwith BE, Tinius KA, Traynor P, Wagner N (1985) Vasopressin reactivates memory after hypothermia induced amnesia. Soc Neurosci Abstr 11: 183–3
Tinius TP, Beckwith BE, Preussler BW (1987) Prenatal administration of arginine vasopressin impairs memory retrieval in adult rats. Peptides 8: 493–499
Tinius TP, Beckwith BE, Oltmanns D (1989) Arginine vasopressin facilitates reversal learning in albino, but not hooded rats. Peptides 10: 237–239
Urban I, De Wied D (1978) Neuropeptides: effects on paradoxical sleep and theta rhythm in rats. Pharmacol Biochem Behav 8: 51–59
Van Haaren F, Van Zanten S, Van de Poll NE (1986) Vasopressin disrupts radial-maze performance in rats. Behav Neural Biol 45: 350–357
Van Ree JM (1982) Neurohypophyseal hormones and addiction. In: Yoshida H, Hagihara Y, Ebashi S (eds) Advances in pharmacology and therapeutics, vol 1. Pergamon, Oxford, pp 199–209
Van Ree JM (1987) Reward and abuse: Opiates and neuropeptides. In: Engel J, Oreland L (eds) Brain reward systems and abuse. Raven, New York, pp 75–88
Van Ree JM, De Wied D (1976) Prolyl-leucyl-glycinamide ( PLG) facilitates morphine dependence. Life Sci 19: 1331–1340
Van Ree JM, De Wied D (1977) Heroin self-administration is under control of vasopressin. Life Sci 21: 315–320
Van Ree JM, De Wied D (1983) Behavioral effects of endorphins — modulation of opiate reward by neuropeptides related to pro-opiocortin and neurohypophyseal hormones. In: Smith JE, Lane JD (eds) The neurobiology of opiate reward processes. Elsevier, Amsterdam, pp 109–145
Van Ree JM, Bohus B, Versteeg DHG, De Wied D (1978) Neurohypophyseal principles and memory processes. Biochem Pharmacol 27: 1793–1800
Van Ree JM, Hijman R, Jolies J, De Wied D (1985) Vasopressin and related peptides: animal and human studies. Prog Neuro psychopharmacol Biol Psychiatry 9: 551–559
Van Ree JM, Burbach-Bloemarts EMM, Wallace M (1988) Vasopressin neuropeptides and acquisition of heroin and cocaine seld-administration in rats. Life Sci 42: 1091–1099
Van Wimersma Greidanus TB (1982) Disturbed behaviour and memory of the Brattleboro rat. Ann NY Acad Sci 394: 655–662
Van Wimersma Greidanus TB, De Wied D (1976) Modulation of passive avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum. Behav Biol 18: 325–333
Van Wimersma Greidanus TB, Veldhuis HD (1985) Vasopressin: site of behavioral action and role in human performance. Peptides 6 [Suppl 2]: 177–180
Van Wimersma Greidanus TB, Bohus B, De Wied D (1973) Effects of peptide hormones on behavior. Prog Endocrinology 273: 197–201
Van Wimersma Greidanus TB, Dogterom J, De Wied D (1975a) Intraventricular administration of anti-vasopressin serum inhibits memory consolidation in rats. Life Sci 16: 637–644
Van Wimersma Greidanus TB, Bohus B, De Wied D (1975b) The role of vasopressin in memory processes. Progr Brain Res 42: 135–141
Van Wimersma Greidanus TB, Tjon Kon Fat-Brontstein H, Van Ree JM (1978) Antisera to pituitary hormones modulate development of tolerance to morphine. In: Van Ree JM, Terenius L (eds) Characteristics and function of opioids. Elsevier, Amsterdam, pp 73–74
Van Wimersma Greidanus TB, Van Ree JM, Versteeg DHG (1980) Neurohypophyseal peptides and avoidance behavior: the involvement of vasopressin and oxytocin in memory processes. In: Ajmone Marsan C, Traczyk WZ (eds) Neuropeptides and neural transmission. Raven, New York, pp 293–300
Van Wimersma Greidanus TB, Van Ree JM, De Wied D (1983a) Vasopressin and memory. Pharmacol Ther 20: 437–458
Van Wimersma Greidanus TB, Bohus B, Kovacs GJ, Versteeg DHG, Burbach JPH, De Wied D (1983b) Sites of behavioral and neurochemical action of ACTH-like peptides and neurohyophyseal hormones. Neurosci Biobehav Rev 7: 453–463
Van Wimersma Greidanus TB, Jolles J, De Wied D (1985) Hypothalamic neuropeptides and memory. Acta Neurochir (Wien) 75: 99–105
Van Wimersma Greidanus TB, Burbach JPH, Veldhuis HD (1986) Vasopressin and oxytocin: their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory. Acta Endocrinol [Suppl] (Copenh) 276: 85–94
Vawter MP, Green KF (1980) Effects of desglycinamide-lysine vasopressin on a conditioned taste aversion in rats. Physiol Behav 25: 851–854
Walter R, Van Ree JM, De Wied D (1978) Modification of conditioned behaviour of rats by neurohypophyseal hormones and analogues. Proc Natl Acad Sci USA 75: 2493–2496
Wang S (1972) Synthesis of desglycinamide lysine vasopressin and its behavior activity in rats. Biochem Biophys Res Commun 48: 1511–1515
Wit JM, Hijman R, Jolles J, Wilters WHG, Van Ree JM, Van den Brande JL, De Wied D (1986) Effect of desglycinamide-arginine8-vasopressin (DGAVP) on cognitive functions in children with memory disorders. Symposium neuropeptides and brain function, Utrecht, May 28–30, 1986 (abstracts), p106 - P55
Zager EL, Black PML (1985) Neuropeptides in human memory and learning processes. Neurosurgery 17: 355–369
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Van Wimersma Greidanus, T.B., Van Ree, J.M. (1990). Behavioral Effects of Vasopressin. In: Ganten, D., Pfaff, D. (eds) Behavioral Aspects of Neuroendocrinology. Current Topics in Neuroendocrinology, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75837-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-75837-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75839-3
Online ISBN: 978-3-642-75837-9
eBook Packages: Springer Book Archive